NYXH Nyxoah SA

NASDAQ
$0.89

Nyxoah SA (NYXH) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.20 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.7% since its last earnings release on November 5, 2026.

Nyxoah SA Beat Consensus Estimates, Reaffirms Below Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.20)
Rev est $15.9M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.87

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Nyxoah SA

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA).

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.